Rainbow Childrens Medicare Limited — Investor Meet, 15-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

**Financial Performance:** In Q3 FY25, Rainbow Children's Medicare reported a robust 18.5% year-over-year growth in revenue, reaching ₹398 crore, while EBITDA increased 14% to ₹134.3 crore. Profit after tax (PAT) rose by 10.2% to ₹68.9 crore. The EBITDA margin for the quarter was 33.8%, and occupancy rates improved, with mature hospitals achieving 60.2% occupancy compared to 39.6% for newer facilities.

**Future Outlook and Growth Drivers:** Management emphasized continued growth from new hospitals launched in key locations such as Hyderabad, Bangalore, and Chennai, alongside ongoing expansion in IVF services and the introduction of Butterfly Essentials retail stores. A state-of-the-art Child Development Center has been established to enhance care offerings.

**Order Book and Operational Updates:** New outpatient clinics have been opened, and the 100-bed regional hub hospital in Rajahmundry is set to commence operations by May 2025. Progress continues at two additional hospitals in Bangalore, while a new 130-bed facility in Coimbatore faces slight delays.

**Analyst Q&A Insights:** Analysts inquired about profitability and potential operational challenges. Management affirmed strong performance despite challenges in the international business, which dipped due to geopolitical factors. Future capacity plans include significant bed additions, with an emphasis on investment in staffing and facilities to support evolving pediatric healthcare needs.

**Market or Regulatory Updates:** The call largely focused on operational growth and market dynamics. No significant regulatory impacts were reported.

**Strategic Focus Areas:** The management's commitment to innovation and expansion was highlighted, aligning with market trends indicating increased demand for specialized pediatric care.

**Investor Insight:** The financial strength, growth trajectory, and focus on operational efficiency suggest a ‘buy’ stance, contrasting the temporary challenges faced in certain international markets and the ramp-up period for new facilities. Overall, the company’s proactive strategies appear capable of sustaining growth even in a fluctuating market environment.